Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation - Wikidata - wikimedia - TriplyDB

Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation

Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation

http://www.wikidata.org/entity/Q33564130

about

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter Human homologue of murine tumor rejection antigen gp96: 5'-regulatory and coding regions and relationship to stress-induced proteins Human neoplasms elicit multiple specific immune responses in the autologous host Fever therapy revisited Human tumor antigens recognized by T lymphocytes A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes Tumor neoantigens: building a framework for personalized cancer immunotherapy Inflammation and cancer, the mastocytoma P815 tumor model revisited: triggering of macrophage activation in vivo with pro-tumorigenic consequences Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68 Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice Structure of the gene of tum- transplantation antigen P35B: presence of a point mutation in the antigenic allele Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action.Embryonal carcinoma cells express Qa and Tla class I genes of the major histocompatibility complex.Current status of interleukin-10 and regulatory T-cells in cancer T-cell antigens in cancer IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases.Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes The tumor-rejection antigens of the 1591 ultraviolet fibrosarcoma. Potential origin and evolutionary implications Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells.Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma.A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma.Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors.Promises and limitations of murine models in the development of anticancer T-cell vaccines.Tum- antigens, TSTA, and T cell immune surveillance.PR1 vaccination in myeloid malignancies.Effect of interleukin 12 on tumor induction by 3-methylcholanthrene Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes.Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer.Advances in personalized cancer immunotherapy.Cancer Immunogenomics: Computational Neoantigen Identification and Vaccine Design.

P2860

Q24307739-EFD80978-541B-4980-A62A-ED6616212244 Q24554402-9ABE1C82-78A8-47F9-8DF2-88EC000875B8 Q24557556-060CBF7E-B1CB-4B72-B4EF-6341908AD6AA Q24564371-075313DF-FF5A-4554-B86A-CD2DC0DE36A7 Q24650460-E060EA66-0059-466D-8604-19E9828B3FEE Q24678508-0AE74553-B3AF-499A-BC5C-19929A9A1188 Q24679739-D7EEB52A-2D4C-473C-8971-B8FD3B508929 Q24680097-D0D841D3-1BAA-4019-9513-7A38C4522BAC Q28082704-D435F686-3DFC-49F0-9B94-802EFD246EA3 Q28193430-2ACADE2B-01D8-481D-8155-E915A0CB35B3 Q28365033-AF35D316-024F-4ECA-B22E-A91E7EFCB36A Q30442838-684BBC57-61AF-4015-9089-1247DE435CC9 Q33255829-C0EAEC34-0013-4457-94FE-727773E6DC2F Q33387226-4AF21E99-6F0A-4EE7-97A7-2085DBAC7336 Q33751018-B8ADD528-97FF-48B9-8C8A-5FCB5F7D0DFB Q33859470-4F177EF5-4FB3-4F7F-B107-960382E92BF3 Q34287252-321BF7C7-9BFF-4D51-8A83-8DAA92741188 Q34374026-B544E88E-A697-4161-9722-C7749F62F11F Q35179337-835CB045-8384-4CF5-B773-760CAE25DE01 Q35950374-DC556411-5852-471D-90C0-83A60CCF1327 Q36082419-3F9B1342-11B0-4B27-A222-F82FA6432DF7 Q36091993-D7440975-5F17-4324-AC42-F0D954CDD075 Q36231676-FB598758-62EE-40D2-96DA-70DB050384D2 Q36356160-12152375-4527-4BBE-A729-9F604838B989 Q36356571-5A04BEEC-86A9-4EB7-ABBD-2E3B508F6EF7 Q36356745-63CF36D6-87D9-46A2-A86F-F31EB722216A Q36362111-39D5070C-E899-4422-AE20-37A2C638A52F Q36366872-2B84CA23-95E4-492E-9DC4-DE52DEE1ABF4 Q36380492-79C29652-710E-4D36-9EBA-D12505056E47 Q36402716-85A8A39F-18F8-465E-8E8B-F4FEE21FED6E Q36684482-20136589-BE45-496A-95DF-ACB829B86299 Q36968849-9F351605-2037-4942-AC1D-2F4E9E451A7C Q37259568-7B4874D9-6542-4269-9BDF-2FA5F1784BA1 Q37269591-F4EB67E4-0A05-46D2-9D8F-33B02BE25A8E Q37360526-8EFF5413-974B-48B2-86BF-B91B1E4034F8 Q37851050-F2B7D5E4-226D-4D9A-9F8B-58F68F2BC812 Q38730989-35283792-7822-4738-A7A8-E6656AC60625 Q38753386-7C265DED-950C-421A-9BB0-4F827747FB94 Q38783946-9B80DEEC-A9DB-4163-AB23-1FC95B47110A Q38847147-921A5563-5912-4815-834E-7A241CA45877

P2860

Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation

http://www.wikidata.org/entity/Q33564130

description

1988 nî lūn-bûn

@nan

1988 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

name

Immunogenic (tum-) variants of ...... ification of the tum- mutation

@ast

Immunogenic (tum-) variants of ...... ification of the tum- mutation

@en

Immunogenic

@nl

type

label

Immunogenic (tum-) variants of ...... ification of the tum- mutation

@ast

Immunogenic (tum-) variants of ...... ification of the tum- mutation

@en

Immunogenic

@nl

prefLabel

Immunogenic (tum-) variants of ...... ification of the tum- mutation

@ast

Immunogenic (tum-) variants of ...... ification of the tum- mutation

@en

Immunogenic

@nl

P1433

Q33564130-EB09145C-BC9B-49BA-B4E0-D420483EC9DD

P1476

Q33564130-CC59CCB1-BFD0-489E-8A4B-F59FE2182393

P2093

Q33564130-0AE7C82F-9482-43C8-A519-AB156B895F77

Q33564130-319134EE-DB4C-477C-8AA1-42C2FC7EB6E9

Q33564130-35003F13-CBC4-4656-B5C9-E4D5861069A5

Q33564130-5D317E08-BC72-480A-A9DE-05B871CD7ADB

Q33564130-80E4B3E6-2349-416A-85ED-0A75382F8D75

Q33564130-8C67A8A8-0AF1-4B8D-83A3-E1EBB6FFE58B

Q33564130-8DF631E8-B092-44CD-801F-1BE5244BA187

Q33564130-A4366576-A0B4-4D52-8EE2-30B451DEBDDB

Q33564130-A513CD1E-C75C-48A6-8306-6D62BCB9C373

P2860

Q33564130-0E86FF4B-CA0A-4ED5-A27B-A047D5D8F53D

Q33564130-121E88D1-7EDE-4C6A-A076-F6C0F4045F68

Q33564130-14DAD3C5-E60C-488B-8914-F09B4A217B8D

Q33564130-18697B7E-4001-454F-B120-55DC238F0FC9

Q33564130-24FE5572-7327-47AF-BE96-057E14033ECB

Q33564130-36686F3F-9FFC-40D9-8A33-6322F4301126

Q33564130-389D7E08-CC5F-42BB-BBC6-4BC8F65F2A9E

Q33564130-3C721459-A554-48B3-935A-B3FDAA945EDD

Q33564130-47D5303E-FC32-452B-BAD6-26D83B0BC9DF

Q33564130-59890A23-ECF1-4AF1-A08A-B962692549E6

P304

Q33564130-AA6B66F2-C1EF-448C-9439-A9629E54A999

P31

Q33564130-C5CCC0C6-BF48-4F7F-A27F-826D7F786D7F

P356

Q33564130-CB9DE138-2524-4AC5-8804-45457D2C3976

P407

Q33564130-02D84EEC-8491-4507-88D9-34650B9C4E07

P433

Q33564130-1DDC1974-DB8E-4291-A1AA-5FEFE9BA0688

P478

Q33564130-0E261FDA-53D3-4321-B57E-C61F59A8DA23

P577

Q33564130-F0B496D2-CCB7-4E5D-AD9A-270F33CEFB83

P5875

Q33564130-573431F1-9B57-40D5-BEF1-4200DD86F5A2

P698

Q33564130-6DF3ED75-ED1C-48AC-8237-941E37EED3F3

P932

Q33564130-A82EAAEF-7ADD-4117-B0B8-F35E242D9033

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Immunogenic (tum-) variants of ...... ification of the tum- mutation

@en

P2093

Boon T

http://www.w3.org/2001/XMLSchema#string

Chomez P

http://www.w3.org/2001/XMLSchema#string

De Plaen E

http://www.w3.org/2001/XMLSchema#string

Lurquin C

http://www.w3.org/2001/XMLSchema#string

Mariamé B

http://www.w3.org/2001/XMLSchema#string

Sibille C

http://www.w3.org/2001/XMLSchema#string

Szikora JP

http://www.w3.org/2001/XMLSchema#string

Van Pel A

http://www.w3.org/2001/XMLSchema#string

Wölfel T

http://www.w3.org/2001/XMLSchema#string

P2860

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

Detection of specific sequences among DNA fragments separated by gel electrophoresis

Rapid and sensitive protein similarity searches

Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination

Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA

5'-structural analysis of genes encoding polymorphic antigens of chemically induced tumors.

A mouse tumor-specific transplantation antigen is a heat shock-related protein.

The construction of cosmid libraries which can be used to transform eukaryotic cells

Inhibition of restriction endonuclease Nci I cleavage by phosphorothioate groups and its application to oligonucleotide-directed mutagenesis

Isolation of transforming DNA by cosmid rescue.

P304

2274-2278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.85.7.2274

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

1988-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20028118

http://www.w3.org/2001/XMLSchema#string

P698

3127830

http://www.w3.org/2001/XMLSchema#string

P932

279973

http://www.w3.org/2001/XMLSchema#string